Vol.38，No. 2，Sep. 2010　The use of Bayesian statistics in clinical trials
　 　
Contents
 
●EditorialTsubaki H260
 
●Review  
　Statistical principles for clinical evaluationTsubaki H261-8
 
●The use of Bayesian statistics in clinical trials  
　Introduction to Bayesian statisticsMatsuyama Y269-79
　Applications of Bayesian statistics to early phase cancer clinical trialsMorita S281-90
　Guidance for Industry and FDA Staff
　　Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
　　 　　U.S. Department of Health and Human Services，
　　 　　Food and Drug Administration (FDA)，
　　 　　Center for Devices and Radiological Health (CDRH)，et al.		 (trans. by Teramukai S，Daimon T) 291-326
　On the FDA guidance for the use of Bayesian statistics in medical device
　　 clinical trials		Teramukai S，Daimon T327-34
 
●Interview 
　Interview with Prof. David Yang
　　PET molecular imaging, drug development, and FDA guidance		Yang D
(Interview and supervising trans. by Inoue T，Kurihara C)		335-52
　Commentary on the interview with Prof. David Yang
　　PET molecular imaging in the RDRC system and drug development
　 　in United States		Kurihara C，Inoue T353-8
 
●Lecture  
　Lecture by Dr. Cate Howell 　　Keeping the blues away:
　　The ten-step guide to reducing the relapse of depression		Howell C359-73
　Relapse-recurrence prevention of depressive disorders:
　　Review of the literature with an impression on the lecture
　　 of Dr. Cate Howell in Tokyo 2010		Saio T375-8
 
●Articles  
　Unveiling Japanese pricing of biosimilar drugs:
　　To clarify muddied regulatory rules of pricing		Kamada I，Yokoya S379-84
　On extrapolation of animal experimentations to humans: An overviewSaio T，Kurihara C385-92
 
●Translation and article  
　Toward More Uniform Conflict Disclosures:
　　The Updated ICMJE Conflict of Interest Reporting Form		 Drazen JM，de Leeuw PW，Laine C，et al.
(trans. by Saio T，Fukushima Y)		 393-403
　Commentary on the revision of “Uniform Disclosure Form
　　for Potential Conflicts of Interest” by ICMJE		Kurihara C，Saio T405-9
 
●Instructions for authors [Japanese] & [English] 411-6
 
●Editor's noteTsuchiya F417
 


Back to Controller Committee home page
Back to Rinsho Hyoka(Clinical Evaluation)